Clinical trial
Safety Study of Passive Immunization for Patients With Mild to Moderate…
NCT00174525 · Pharmacology Research Institute, Other · Unknown status
Key facts
| NCT number | NCT00174525 |
|---|---|
| Title | Safety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's Disease |
| Official title | A Phase IIA, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Immunogenicity Trial of AAB-001 in Patients With Mild to Moderate AD |
| Lead sponsor | Pharmacology Research Institute, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | AAB-001 |
| Start date | Apr 1, 2005 |
| Completion | Apr 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | May 9, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: